Ameritas Investment Partners, Inc. - ALBANY MOLECULAR RESH INC ownership

ALBANY MOLECULAR RESH INC's ticker is AMRI and the CUSIP is 012423109. A total of 140 filers reported holding ALBANY MOLECULAR RESH INC in Q2 2017. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of ALBANY MOLECULAR RESH INC
ValueSharesWeighting
Q2 2017$44,000
+57.1%
2,0060.0%0.00%
+100.0%
Q1 2017$28,0002,0060.00%
Other shareholders
ALBANY MOLECULAR RESH INC shareholders Q2 2017
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 302,400$4,243,0007.26%
Permian Investment Partners, LP 3,181,577$44,638,0006.90%
OBERMEYER WOOD INVESTMENT COUNSEL, LLLP 1,738,764$24,395,0002.25%
AMERICAN CAPITAL MANAGEMENT INC 2,157,370$30,268,0002.14%
Walthausen & Co., LLC 831,285$11,663,0001.20%
Netols Asset Management, Inc. 371,226$5,208,0001.17%
RICE HALL JAMES & ASSOCIATES, LLC 1,234,440$17,319,0000.84%
AMI ASSET MANAGEMENT CORP 705,493$9,898,0000.74%
Evercore Wealth Management, LLC 1,040,211$14,594,0000.57%
Lombard Odier Asset Management (USA) Corp 421,100$5,908,0000.56%
View complete list of ALBANY MOLECULAR RESH INC shareholders